Clinical Trials Directory

Trials / Terminated

TerminatedNCT00910494

Intraoperative Radiotherapy for Rectal Cancer Using the Photon Radiosurgery System

Intraoperative Radiotherapy (IORT) for Rectal Cancer Using the Photon Radiosurgery System (PRS): A Phase I Clinical Trial

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
University of Dundee · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators would like to test the safety and efficacy of intraoperative radiotherapy (IORT) in rectal cancer using the Photon Radiosurgery System (PRS).

Detailed description

Rectal cancer is usually managed by a combination of surgery and x-ray treatments (radiotherapy). The standard way of delivering radiotherapy is with external 'beams' directed at the tumour site. However, although in rectal cancer these treatments are effective, patients are often troubled by late side effects. An alternative option is to deliver the x-rays at the same time as surgery. This is known as intraoperative radiotherapy, or IORT, and a number of techniques have already been tried. There is a new IORT technology known as the Photon Radiosurgery System (PRS) which we are using to treat breast and brain cancers. Our experience to date has informed us that IORT with this x-ray source is safe and effective. We would like to use the technology to treat rectal cancer and believe that it may improve disease outcomes without the side effects associated with standard radiotherapy. We would also like to study the biological processes that follow radiation. It is not understood why some people are more sensitive to x-ray treatments than others. If we knew the reasons for this then we might be able to individualise treatments.

Conditions

Interventions

TypeNameDescription
RADIATIONPhoton Radiosurgery System IORT
RADIATIONPhoton Radiosurgery System IORT

Timeline

Start date
2010-01-01
Primary completion
2016-03-01
Completion
2016-03-01
First posted
2009-06-01
Last updated
2018-04-24

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00910494. Inclusion in this directory is not an endorsement.